Literature DB >> 698696

Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria.

I Smith, M E Lobascher, J E Stevenson, O H Wolff, H Schmidt, S Grubel-Kaiser, H Bickel.   

Abstract

Forty-seven patients at the Hospital for Sick Children, London, who had phenylketonuria and were on a low-phenylalanine diet (21 early-treated--that is, treatment started before the age of 4 months--and 26 late-treated) were placed on a normal diet between the ages of 5 and 15 years. They showed significant falls in mean IQ of about six points after the diet was withdrawn. Twenty-two similar patients (five early-treated and 17 late-treated) at the Universitäts-Kinderklinik, Heidelberg, who were placed on a relaxed low-phenylalanine rather than a normal diet, showed smaller and non-significant falls in mean IQ. During the period of strict diet none of the patients in London or Heidelberg showed any consistent falls in IQ. These results suggest that complete withdrawal of the low-phenylalanine diet during childhood leads to a fall in intellectual progress in many patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 698696      PMCID: PMC1607584          DOI: 10.1136/bmj.2.6139.723

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  Termination of dietary treatment of phenylketonuria.

Authors:  F A HORNER; C W STREAMER; L L ALEJANDRINO; L H REED; F IBBOTT
Journal:  N Engl J Med       Date:  1962-01-11       Impact factor: 91.245

2.  Influence of phenylalanine intake on phenylketonuria.

Authors:  H BICKEL; J GERRARD; E M HICKMANS
Journal:  Lancet       Date:  1953-10-17       Impact factor: 79.321

3.  Behavioral consequences of increased phenylalanine intake by phenylketonuric children: a pilot study describing a methodology.

Authors:  W K Frankenburg; A D Goldstein; C O Olson
Journal:  Am J Ment Defic       Date:  1973-03

4.  What is the best age to discontinue the low phenylalanine diet in phenylketonuria? A presentation of some contributory data.

Authors:  C F Johnson
Journal:  Clin Pediatr (Phila)       Date:  1972-03       Impact factor: 1.168

5.  Evaluation of treatment begun in first three mohs oflife in 184 cases of phenylketonuria.

Authors:  F P Hudson; V L Mordaunt; I Leahy
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

6.  Intelligence quotients and intelligence loss in patients with phenylketonuria and some variant states.

Authors:  J L Berman; R Ford
Journal:  J Pediatr       Date:  1970-11       Impact factor: 4.406

7.  Termination of dietary treatment in phenylketonuria.

Authors:  B Cabalska; N Duczyńska; J Borzymowska; K Zorska; A Koślacz-Folga; K Bozkowa
Journal:  Eur J Pediatr       Date:  1977-11-04       Impact factor: 3.183

8.  Neurological disturbance in a phenylketonic child after discontinuation of dietary treatment.

Authors:  B Wood
Journal:  Dev Med Child Neurol       Date:  1976-10       Impact factor: 5.449

9.  Results of treatment and termination of the diet in phenylketonuria (PKU).

Authors:  E S Kang; N D Sollee; P S Gerald
Journal:  Pediatrics       Date:  1970-12       Impact factor: 7.124

10.  Mental development of phenylketonuric children on or off diet after the age of six.

Authors:  E S Brown; R Warner
Journal:  Psychol Med       Date:  1976-05       Impact factor: 7.723

View more
  29 in total

1.  Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria.

Authors:  I Smith; M G Beasley; A E Ades
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

2.  Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria.

Authors:  A S Lidsky; F D Ledley; A G DiLella; S C Kwok; S P Daiger; K J Robson; S L Woo
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

Review 3.  Somatic gene therapy for phenylketonuria and other hepatic deficiencies.

Authors:  R C Eisensmith; S L Woo
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Phenylketonuric patients decades after diet.

Authors:  R O Fisch; P N Chang; S Weisberg; P Guldberg; F Güttler; M Y Tsai
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Neurological deterioration in adult phenylketonuria.

Authors:  D Villasana; I J Butler; J C Williams; S M Roongta
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

6.  Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria.

Authors:  Huiling Peng; Dawn Peck; Desirée A White; Shawn E Christ
Journal:  J Inherit Metab Dis       Date:  2013-09-17       Impact factor: 4.982

7.  Long-term follow up of patients with classical phenylketonuria after diet relaxation at 5 years of age. The Paris Study.

Authors:  F Rey; V Abadie; F Plainguet; J Rey
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 8.  Gene therapy for phenylketonuria.

Authors:  R C Eisensmith; S L Woo
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

9.  Intelligence and professional career in young adults treated early for phenylketonuria.

Authors:  H Schmidt; P Burgard; J Pietz; A Rupp
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

10.  Turnover of the fast components of myelin and myelin proteins in experimental hyperphenylalaninaemia. Relevance to termination of dietary treatment in human phenylketonuria.

Authors:  F A Hommes; A G Eller; E H Taylor
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.